ArticleMolecules (Basel, Switzerland)2016

Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders.

Alireza Nematollahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.